Free Trial

Absci (ABSI) Competitors

Absci logo
$2.73 +0.15 (+5.81%)
As of 02:05 PM Eastern

ABSI vs. EVH, RDWR, STGW, DGNX, CTOS, ETWO, YEXT, FVRR, TIXT, and EEX

Should you be buying Absci stock or one of its competitors? The main competitors of Absci include Evolent Health (EVH), Radware (RDWR), Stagwell (STGW), Diginex (DGNX), Custom Truck One Source (CTOS), E2open Parent (ETWO), Yext (YEXT), Fiverr International (FVRR), Telus Digital (TIXT), and Emerald (EEX). These companies are all part of the "business services" industry.

Absci vs. Its Competitors

Absci (NASDAQ:ABSI) and Evolent Health (NYSE:EVH) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Evolent Health has higher revenue and earnings than Absci. Evolent Health is trading at a lower price-to-earnings ratio than Absci, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Absci$4.82M72.32-$103.11M-$0.92-2.97
Evolent Health$2.40B0.58-$61.62M-$1.23-9.71

Absci has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Absci presently has a consensus target price of $8.40, indicating a potential upside of 207.69%. Evolent Health has a consensus target price of $17.79, indicating a potential upside of 48.96%. Given Absci's higher possible upside, research analysts plainly believe Absci is more favorable than Evolent Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Absci
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Evolent Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
3.00

52.0% of Absci shares are owned by institutional investors. 10.5% of Absci shares are owned by insiders. Comparatively, 1.4% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Evolent Health has a net margin of -4.54% compared to Absci's net margin of -2,232.13%. Evolent Health's return on equity of 3.64% beat Absci's return on equity.

Company Net Margins Return on Equity Return on Assets
Absci-2,232.13% -53.69% -45.89%
Evolent Health -4.54%3.64%1.44%

In the previous week, Evolent Health had 1 more articles in the media than Absci. MarketBeat recorded 6 mentions for Evolent Health and 5 mentions for Absci. Absci's average media sentiment score of 0.58 beat Evolent Health's score of 0.09 indicating that Absci is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Absci
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evolent Health
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Absci and Evolent Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Absci News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABSI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABSI vs. The Competition

MetricAbsciMED IndustryMedical SectorNASDAQ Exchange
Market Cap$348.24M$2.88B$5.46B$8.93B
Dividend YieldN/A2.44%5.24%4.04%
P/E Ratio-2.9720.9427.0720.17
Price / Sales72.32194.82381.5293.95
Price / CashN/A41.7026.2128.59
Price / Book1.757.518.015.59
Net Income-$103.11M-$55.04M$3.17B$248.41M
7 Day Performance5.41%5.25%3.53%6.17%
1 Month Performance-9.90%2.30%2.73%7.83%
1 Year Performance-17.27%5.33%34.10%21.03%

Absci Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABSI
Absci
2.0495 of 5 stars
$2.73
+5.8%
$8.40
+207.7%
-18.6%$348.24M$4.82M-2.97210
EVH
Evolent Health
1.562 of 5 stars
$11.31
+1.3%
$17.79
+57.3%
-41.8%$1.31B$2.55B-9.204,500
RDWR
Radware
2.5761 of 5 stars
$29.44
+0.9%
$27.00
-8.3%
+58.1%$1.25B$274.88M109.041,208News Coverage
Analyst Forecast
Gap Up
STGW
Stagwell
2.5514 of 5 stars
$4.50
+0.7%
$9.13
+102.8%
-33.8%$1.20B$2.84B9.9314,607News Coverage
DGNX
Diginex
N/A$51.44
+0.3%
N/AN/A$1.16BN/A0.0021News Coverage
Positive News
CTOS
Custom Truck One Source
0.6057 of 5 stars
$4.96
-1.6%
$5.25
+5.8%
+19.6%$1.14B$1.80B-38.151,800News Coverage
Positive News
ETWO
E2open Parent
1.194 of 5 stars
$3.24
flat
$2.78
-14.4%
-29.0%$1.11B$607.69M-1.513,873Upcoming Earnings
YEXT
Yext
1.636 of 5 stars
$8.52
+0.2%
$9.44
+10.8%
+62.8%$1.04B$420.96M-47.331,150
FVRR
Fiverr International
3.827 of 5 stars
$29.36
+2.5%
$36.00
+22.6%
+22.4%$1.03B$391.48M62.47790
TIXT
Telus Digital
1.5313 of 5 stars
$3.63
+0.8%
$4.05
+11.5%
-34.3%$992.34M$2.66B-7.4178,879
EEX
Emerald
1.9995 of 5 stars
$4.86
-1.6%
$7.90
+62.6%
-7.4%$982.36M$398.80M162.05600

Related Companies and Tools


This page (NASDAQ:ABSI) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners